Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Ampicillin Sodium: β-Lactam Antibiotic for Precision Anti...

    2025-10-25

    Ampicillin Sodium: β-Lactam Antibiotic for Precision Antibacterial Research

    Executive Summary: Ampicillin sodium (CAS 69-52-3) is a β-lactam antibiotic that functions as a competitive inhibitor of bacterial transpeptidase enzymes, disrupting cell wall biosynthesis and causing bacterial lysis (ApexBio). It demonstrates an IC50 of 1.8 μg/ml for E. coli 146 transpeptidase and a MIC of 3.1 μg/ml in standard in vitro assays. The compound is highly soluble (≥18.57 mg/mL in water) and routinely used in protein purification protocols involving recombinant bacterial expression (Burger et al., 1993, DOI). Ampicillin sodium (A2510) is integral for antibiotic resistance modeling and advanced antibacterial activity assays. Its storage, handling, and application parameters are well-defined to ensure experimental reproducibility.

    Biological Rationale

    Ampicillin sodium targets bacterial infections by inhibiting the biosynthesis of peptidoglycan, a key cell wall polymer in both Gram-positive and Gram-negative bacteria (Mechanistic Mastery). The β-lactam structure enables selective binding to penicillin-binding proteins (PBPs), especially transpeptidase enzymes required for cross-linking the cell wall matrix. This selectivity underpins its utility in both clinical and research contexts, including studies on bacterial physiology, antibiotic resistance, and protein expression systems. Unlike narrow-spectrum penicillins, Ampicillin sodium is effective against a broader spectrum of bacteria, supporting its widespread use in translational research (Translational Catalyst).

    Mechanism of Action of Ampicillin sodium

    Ampicillin sodium acts through competitive inhibition of the transpeptidase activity of bacterial PBPs. The β-lactam ring forms a covalent adduct with the active site serine residue in the transpeptidase, blocking cross-linking of peptidoglycan chains (Precision Microbiology). This disruption compromises the structural integrity of the bacterial cell wall, leading to osmotic imbalance and cell lysis.

    • Step 1: Ampicillin sodium diffuses into the periplasmic space of susceptible bacteria.
    • Step 2: The β-lactam moiety mimics the D-Ala-D-Ala terminus of peptidoglycan precursors.
    • Step 3: Irreversible acylation of the transpeptidase active site occurs, halting cell wall crosslinking.
    • Step 4: Loss of peptidoglycan integrity triggers autolytic enzymes, resulting in cell death.

    This mechanism is highly conserved among β-lactam antibiotics but Ampicillin sodium's physicochemical properties (solubility, stability) make it especially versatile for in vitro and in vivo research applications.

    Evidence & Benchmarks

    • Ampicillin sodium inhibits E. coli 146 transpeptidase with an IC50 of 1.8 μg/ml under standard laboratory conditions (pH 7.0, 37°C) (ApexBio).
    • The minimum inhibitory concentration (MIC) against E. coli is 3.1 μg/ml in broth microdilution assays (ApexBio).
    • High water solubility (≥18.57 mg/mL) enables assay flexibility and compatibility with a range of buffers (ApexBio).
    • In recombinant protein purification protocols, Ampicillin sodium at 50 μg/ml is used to maintain selective pressure in E. coli cultures expressing annexin V, with efficacy confirmed by SDS-PAGE and HPLC analysis (Burger et al., 1993, DOI).
    • Purity of ≥98% is consistently verified by NMR, MS, and certificate of analysis for research-grade lots (ApexBio).

    Applications, Limits & Misconceptions

    Ampicillin sodium is a mainstay in antibacterial activity assays, protein expression workflows, and antibiotic resistance research. Its efficacy spans both Gram-positive and Gram-negative bacteria, making it suitable for broad-spectrum applications. In recombinant protein purification, it is routinely used to maintain selective pressure in cultures harboring β-lactamase-sensitive plasmids (Biophysical Studies), extending beyond conventional clinical indications.

    Common Pitfalls or Misconceptions

    • Not effective against β-lactamase-producing strains: Bacterial strains expressing β-lactamase enzymes will degrade Ampicillin sodium, rendering it ineffective unless a β-lactamase inhibitor is also present (Precision Microbiology).
    • Not stable in solution for extended periods: Ampicillin sodium solutions should be freshly prepared; significant loss of potency occurs upon prolonged storage at room temperature (ApexBio).
    • Not suitable for selection in β-lactam-resistant E. coli strains: Use in such strains will not provide effective selective pressure after resistance acquisition.
    • Not a substitute for narrow-spectrum antibiotics: In applications requiring high specificity for Gram-positive cocci, alternative penicillins may be preferable.
    • Not for direct therapeutic use: Research-grade Ampicillin sodium (A2510) is not certified for clinical administration.

    Workflow Integration & Parameters

    For in vitro antibacterial assays, dissolve Ampicillin sodium in sterile water at ≥18.57 mg/mL; filter-sterilize and use immediately. In E. coli expression workflows, supplement LB or other bacterial media with 50–100 μg/mL Ampicillin sodium to maintain plasmid selection. Store dry powder at -20°C; ship with blue ice to preserve stability. Quantitative assays should use freshly prepared solutions to maintain potency. For protein purification, as described in Burger et al. (1993), Ampicillin sodium is essential for plasmid maintenance throughout bacterial culture and induction phases (DOI).

    This article clarifies the experimentally validated concentration ranges, storage requirements, and solubility parameters, extending the guidance provided in Ampicillin Sodium: Mechanistic Mastery by focusing on recent reproducibility standards and limits of use.

    Conclusion & Outlook

    Ampicillin sodium, as a well-characterized β-lactam antibiotic and competitive transpeptidase inhibitor, continues to serve as a precision tool for researchers in antibacterial activity, resistance modeling, and protein purification. Its robust mechanistic basis, high solubility, and reproducible activity metrics underpin its role in contemporary workflows. Ongoing advancements in resistance detection and biophysical assay design are likely to further refine its application scope, especially as protocols are updated for emerging bacterial challenges. For detailed product parameters and QC documentation, consult the Ampicillin sodium (A2510) product page.

    For a broader strategic perspective on integrating Ampicillin sodium into next-generation research, see the in-depth reviews at Ampicillin Sodium as a Translational Catalyst (which this article updates by detailing atomic IC50/MIC values) and Precision Tool for Biophysical and Structural Studies (which is extended here by mapping specific workflow integration steps).